These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 28170096)

  • 61. Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy.
    Lee S; Watson MW; Flexman JP; Cheng W; Hammond T; Price P
    J Med Virol; 2010 Apr; 82(4):568-74. PubMed ID: 20166183
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.
    Wang H; Grzywacz B; Sukovich D; McCullar V; Cao Q; Lee AB; Blazar BR; Cornfield DN; Miller JS; Verneris MR
    Blood; 2007 Sep; 110(5):1530-9. PubMed ID: 17495133
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cyclic changes and relationship between peripheral and endometrial NK cells from women with repeated failure after artificial insemination by donor sperm.
    Zhang Y; Kwak-Kim J; Huang D; Hu L; Liao A
    Am J Reprod Immunol; 2014 Jan; 71(1):44-54. PubMed ID: 24102854
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CD56
    Ma M; Yin X; Zhao X; Guo C; Zhu X; Liu T; Yang M; Zhang Z; Fu Y; Liu J; Xu J; Ding H; Han X; Chu Z; Shang H; Jiang Y
    J Leukoc Biol; 2019 Dec; 106(6):1313-1323. PubMed ID: 31483071
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
    Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
    J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early Cytomegalovirus Reactivation and Expansion of CD56
    Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation.
    De Maria A; Bozzano F; Cantoni C; Moretta L
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):728-32. PubMed ID: 21187373
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.
    Harmon C; Robinson MW; Fahey R; Whelan S; Houlihan DD; Geoghegan J; O'Farrelly C
    Eur J Immunol; 2016 Sep; 46(9):2111-20. PubMed ID: 27485474
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.
    Domaica CI; Fuertes MB; Uriarte I; Girart MV; Sardañons J; Comas DI; Di Giovanni D; Gaillard MI; Bezrodnik L; Zwirner NW
    PLoS One; 2012; 7(12):e51677. PubMed ID: 23240056
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Interferon-α mediating the functional damage of CD56
    Zhao XG; Liu JQ; Huang HN; Lu ZM; Bai ZR; Li X; Qi JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):975-981. PubMed ID: 38101777
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.
    Pesce S; Squillario M; Greppi M; Loiacono F; Moretta L; Moretta A; Sivori S; Castagnola P; Barla A; Candiani S; Marcenaro E
    Front Immunol; 2018; 9():2360. PubMed ID: 30374356
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection.
    Titanji K; Sammicheli S; De Milito A; Mantegani P; Fortis C; Berg L; Kärre K; Travi G; Tassandin C; Lopalco L; Rethi B; Tambussi G; Chiodi F
    Immunology; 2008 Feb; 123(2):164-70. PubMed ID: 17627773
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells.
    Márquez ME; Millet C; Stekman H; Conesa A; Deglesne PA; Toro F; Sanctis JD; Blanca I
    Cell Immunol; 2010; 264(1):86-92. PubMed ID: 20553754
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56(dim) natural killer cells.
    Merkt W; Claus M; Blank N; Hundemer M; Cerwenka A; Lorenz HM; Watzl C
    Arthritis Res Ther; 2016 Sep; 18(1):204. PubMed ID: 27624647
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Decrease in the Frequency of Circulating CD56
    Rai AK; Thakur CP; Kumar P; Saini S; Kureel AK; Kumari S; Seth T; Mitra DK
    Immunol Invest; 2018 Feb; 47(2):125-134. PubMed ID: 29182405
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expansion of CD56
    Casado JL; Moraga E; Vizcarra P; Velasco H; Martín-Hondarza A; Haemmerle J; Gómez S; Quereda C; Vallejo A
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062250
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The CD16-/CD56bright subset of NK cells is resistant to oxidant-induced cell death.
    Thorén FB; Romero AI; Hermodsson S; Hellstrand K
    J Immunol; 2007 Jul; 179(2):781-5. PubMed ID: 17617567
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation.
    Morandi F; Horenstein AL; Chillemi A; Quarona V; Chiesa S; Imperatori A; Zanellato S; Mortara L; Gattorno M; Pistoia V; Malavasi F
    J Immunol; 2015 Aug; 195(3):965-72. PubMed ID: 26091716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.